is glp-1 safe for kidneys and the kidney: from physiology to pharmacology and outcomes in diabetes RACGP - GLP-1 receptor agonists

World J Gastroenterol (2014) 20:1482130

Dipeptidyl peptidase 4 inhibitor use is associated with a lower risk of incident acute kidney injury in patients with diabetes

But the gap between "berberine has some evidence when swallowed at 1,500 mg" and "a patch with 8.75 mg of berberine will help you lose weight through your skin" is a canyon, and the marketing fills that canyon with aspiration rather than data

"With tens of millions of customer touch points annually in the closed-loop provider network, we are amassing a powerful data set that is becoming harder to replicate

When paying out of pocket, prices vary wildly across medications

9 reports of biliopancreatic bypass with/without duodenal switch showed 74.1% EWL